Gene Query: VWA1

Dataset Description Geneva Score
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 92.3
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 79.77
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 79.77
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 73.42
TCF7L1 knockdown in pancreatic cancer 68.43
Genetic-to-epigenetic Therapy for Pancreatic Cancer 62.74
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 53.95
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 52.06
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 51.94
Silencing SPIB in attached and floating state of H1703 lung cancer cells 47.92
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 45.73
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 45.73
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 37.06
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 35.3
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 34.82
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 34.26
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 32.91
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 31.66
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 31.22
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 30.41
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 30.2
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 29.13
MARS Seq data from human cortical organoids 28.18
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 27.89
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 26.01
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 25.38
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 24.65
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 24.49
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 24.49
TGF-β regulation of miRNA expression in pancreatic cancer 23.76
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 23.65
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 23.44
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 22.42
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 21.22
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 21.01
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 21.01
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 20.67
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 20.22
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 19.99
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 19.8
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 19.71
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 19.71
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 19.4
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 19.4
Non-coding regions are the main source of tumor-specific antigens [human] 18.68
Non-coding regions are the main source of tumor-specific antigens 18.68
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 18.34
RNA-seq analysis of the human fetal kidney. 18.1
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 18.08
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 17.71
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 17.53
H1609088 Human RNA-Sequencing 17.51
JAK dependent survival of ALK- ALCL 16.76
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 16.71
Transcriptome analysis of virus infected tissues 16.54
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 16.35
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 16.03
Total RNA sequencing of WT intestinal orgaonids. 16.0
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 15.87
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 15.87
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 15.7
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 15.46
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 15.22
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 15.22
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 15.03
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 14.87
Transciptomic profiling of human fetal lung samples 14.8
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 14.42
FOXD3 is a novel tumor suppressor in lung cancer 14.27
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 14.19
AMPK signaling for naïve pluripotency [Hs] 14.01
AMPK signaling for naïve pluripotency 14.01
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 13.96
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 13.95
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 13.82
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 13.78
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 13.73
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 13.7
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 13.54
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 13.54
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 13.48
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 13.42
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 13.42
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 13.26
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 13.11
RNA-seq of human aneuploid cell lines with Trisomy 21 13.07
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 12.95
Transcriptomic profile of human embryonic renal corpuscles 12.94
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 12.91
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 12.91
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 12.89
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 12.8
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 12.42
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 12.27
Characterization of parental and rociletinib-resistant derived H1975 cell lines 12.26
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 12.25
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 12.21
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 12.16
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 12.11
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 12.1
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 12.07
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 12.05
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 11.98
HNRNPM-regulated splicing dependencies in prostate cancer 11.98
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 11.93
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 11.88
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 11.71
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 11.7
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 11.67
LNCaP treated with iBET 11.64
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 11.62
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 11.37
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 11.36
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 11.03
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 11.03
The age and genomic integrity of neurons after cortical stroke in humans 10.98
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 10.97
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 10.96
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 10.96
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 10.77
Functional Haploid Human Oocytes Generated from Polar Body Genomes 10.77
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 10.69
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 10.69
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 10.66
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 10.63
CD73 knockdown effect in pancreatic cancer cell lines 10.59
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 10.52
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 10.42
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 10.39
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 10.39
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 10.38
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 10.36
Transcriptional effect of ETV1 knockdown in melanoma cells 10.3
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 10.27
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 10.19
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 10.15
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 10.14
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 10.14
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 9.9
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 9.89
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 9.81
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 9.79
RNA Sequencing of three pairs of gastric cancer 9.78
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 9.75
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 9.67
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 9.67
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 9.58
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 9.57
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 9.54
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 9.41
LncRNA-GAS5 negative regulation of YAP-target genes expression 9.38
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 9.23
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 9.18
RNA-seq analysis of BAP1-depleted uveal melanoma cells 9.1
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 9.09
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 8.99
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 8.98
Nonpregnant and term pregnant human myometrial tissues 8.98
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 8.85
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 8.84
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 8.81
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 8.76
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 8.76
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 8.71
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 8.71
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 8.69
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 8.58
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 8.58
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 8.56
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 8.36
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 8.35
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 8.28
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 8.26
Lipid degradation promotes prostate cancer cell survival 8.21
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 8.18
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 8.16
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 8.15
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 8.08
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 8.06
Transcriptome analysis of kidney organoids 8.04
Paxillin regulates genomic networks in prostate cancer [LNCaP] 8.02
Human optic chiasm from healthy controls and multiple sclerosis patients 7.82
Multiple sclerosis and EAE 7.82
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 7.77
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 7.75
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 7.7
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 7.62
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 7.59
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 7.51
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 7.51
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 7.48
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 7.45
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 7.43
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 7.4
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 7.4
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 7.39
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 7.39
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 7.38
Zone dependent distinctive gene expression profile of the normal human liver tissue 7.36
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 7.25
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 7.22
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 7.03
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 6.98
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 6.96
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 6.96
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 6.94
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 6.94
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 6.88
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 6.88
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 6.84
mRNA-Seq profiling of human developing kidney 6.81
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 6.8
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 6.8
Next Generation Sequencing of human SMA and healthy control Motor Neurons 6.79
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 6.77
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 6.75
Transcriptome analysis of human lung epithelial cells 6.69
Depicting early human development and germ cell origin with porcine embryos 6.66
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 6.65
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 6.65
SNHG5 siRNA knock down in HCT116 cells 6.64
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 6.64
T47D RNA-seq and ChrRNA-seq data 6.64
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 6.64
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 6.63
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 6.63
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 6.63
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 6.63
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 6.55
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 6.52
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 6.49
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 6.41
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 6.39
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 6.33
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 6.3
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 6.21
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 6.18
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 6.12
RNA seq analysis of human Fetal and adult derived Enterospheres 6.11
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 6.09
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 6.07
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 6.07
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 6.06
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 5.99
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.99
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 5.83
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 5.79
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 5.77
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 5.76
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 5.76
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 5.76
Morphological and molecular characterization of human dermal lymphatic collectors 5.73
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 5.72
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 5.71
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 5.68
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 5.68
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 5.65
RNA-Sequencing of HepG2 cells treated with TGFBeta 5.64
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 5.62
Epigenomic conservation of transposable element silencing [RNA-seq] 5.6
Epigenomic conservation of transposable element silencing 5.6
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 5.58
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 5.55
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 5.55
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 5.54
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 5.5
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 5.44
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 5.42
Reprogrammed myeloid cell transcriptomes in NSCLC 5.41
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 5.4
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 5.4
Paxillin regulates genomic networks in prostate cancer [C4-2] 5.4
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 5.36
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 5.32
Hepatocyte maturation 5.24
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 5.23
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 5.21
Gene expression analysis of human liver progenitor-like cells in culture 5.2
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 5.14
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 5.14
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 5.12
Gene expression analysis of human hepatocellular cancers 5.12
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 5.01
RNA Seq of Alagille liver biopsies 4.8
Alagille_Nodder 4.8
Gene expression analysis of dengue-infected cells 4.79
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 4.76
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 4.75
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 4.75
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 4.72
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 4.67
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 4.67
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 4.59
Induced DNA demethylation, genome instability and transcription 4.59
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 4.55
RNA sequencing of human pancreatic cancer cell lines 4.53
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 4.52
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 4.52
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 4.51
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 4.51
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 4.42
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 4.41
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 4.41
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 4.41
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 4.4
NKX2.2 4.4
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 4.39
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 4.35
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 4.25
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 4.24
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 4.17
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.17
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 4.17
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 4.11
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 4.11
Epigenome regulation during epidermal lineage commitment 4.09
Ro60-knockout cells 4.04
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.99
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.99
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 3.98
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 3.95
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 3.93
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 3.92
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 3.91
Redifferentiation of expanded human islet β cells by inhibition of ARX 3.82
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 3.81
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 3.8
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 3.77
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 3.75
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 3.75
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 3.68
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 3.66
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 3.64
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 3.63
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 3.6
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 3.6
Global analyses of the effect of different cellular contexts on microRNA targeting 3.57
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 3.57
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.47
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 3.47
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 3.47
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 3.46
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 3.44
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 3.44
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 3.41
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 3.37
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 3.34
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 3.33
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 3.33
Dermal endothelial cells of type 2 diabetic patients 3.32
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 3.27
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 3.24
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 3.24
CSL 3.23
CSL RNA-Seq on HKC and SCC cell lines 3.23
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 3.19
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 3.15
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 3.12
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 3.09
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 3.0
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 2.98
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 2.94
2.92
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 2.9
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 2.9
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 2.85
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 2.79
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 2.76
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 2.69
Transcriptional responses of melanoma cells to BRAF inhibition 2.67
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 2.6
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 2.58
RNA-seq of naive and primed ES cells 2.53
Molecular Criteria for Defining the Naive Human Pluripotent State 2.52
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 2.5
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 2.49
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 2.49
Hepatic transcriptome of pediatric hepatoblastoma. 2.43
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 2.43
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 2.43
Epigenome regulation during epidermal lineage commitment [RNA-seq] 2.42
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 2.41
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 2.39
The expression profiles of GBC liver metastasis 2.34
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 2.28
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.25
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 2.25
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 2.25
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 2.24
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.22
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 2.18
Iron response of HepG2 cells 2.17
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 2.14
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 2.14
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 2.13
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 2.13
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.05
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 2.04
Deep RNA sequencing of the human placental transcriptome 2.03
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 1.99
Gene expression patterns define the hepatocyte-like cells derived by different strategies 1.99
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.9
FGF2 regulation of gene expression in stable inducible Neurons 1.89
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 1.85
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.8
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.74
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 1.72
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 1.67
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 1.67
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 1.65
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 1.56
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 1.56
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 1.53
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 1.5
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 1.49
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 1.49
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.48
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.48
RNA expression profiles comparing primary and omental ovarian carcinoma samples 1.46
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 1.44
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 1.42
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 1.42
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.4
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.4
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 1.39
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 1.31
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.31
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 1.31
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 1.31
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.25
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.25
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 1.23
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.23
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.21
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 1.21
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.17
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 1.13
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 1.13
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 1.09
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 1.09
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.08
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 1.06
RNA-seq analysis of breast cancer 1.04
RNA-seq analysis and shRNA screen of breast cancer 1.04
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.04
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.04
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.04
circNFIB suppresses lymphatic metastasis of pancreatic cancer 1.02
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 1.01
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.0
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.96
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.96
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.93
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.92
The DNA methylation landscape of human melanoma [RNA-Seq] 0.92
The DNA methylation landscape of human melanoma 0.92
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.86
Expression profiling of converted and control dermal BJ fibroblasts 0.86
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.86
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.86
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 0.83
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 0.83
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.81
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.75
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.75
Loss of endometrial plasticity in recurrent pregnancy loss 0.66
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 0.66
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.62
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.61
Gene expression profile of CRC-derived HILEC 0.56
Human islets of varying quality: the good, the (not so) bad and the ugly 0.56
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 0.56
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.55
mRNA-sequencing of breast cancer subtypes and normal tissue 0.46
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 0.42
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 0.41
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.4
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.38
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.38
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.34
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.32
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.3
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 0.29
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.28
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.25
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.24
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.21
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.2
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 0.16
Measure transcript integrity using RNA-seq data 0.14
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.13
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.12
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.11
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.09
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.07
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.06
Gene expression analysis of breast cancer cell-lines 0.06
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.01
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.0
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation